CorrectionPublished 15 September 2026Correction: A two-tier protection strategy for oral delivery of GLP-1 peptides: lipid-based formulation combined with enteric capsulesCamille Dumont · Vanessa Gonzalez · Paula Klatt · Sandrine Picco · Delphine Nombret · Marine Agisson · Euengla Uku · Thibault Saurel · Vincent JanninFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1973549
Original ResearchPublished 3 June 2026Antiparasitic triterpenic ester and ursolic acid lipid nanocapsule design, cytotoxicity, and permeability evaluation for oral deliveryLaura Schioppa · Cecilia Bohns Michalowski · Lucia Mamede · Romano Terrasi · Marie-France Hérent · Giulio G. Muccioli · Raphaël Frédérick · Michel Frederich · Ana Beloqui · Joelle Quetin-LeclercqFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1846904
PerspectivePublished 1 June 2026The fourth controlled release society workshop on oral peptide administrationDavid J. Brayden · Stephen T. Buckley · Andrew L. LewisFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1860678
Original ResearchPublished 22 May 2026A two-tier protection strategy for oral delivery of GLP-1 peptides: lipid-based formulation combined with enteric capsulesCamille Dumont · Vanessa Gonzalez · Paula Klatt · Sandrine Picco · Delphine Nombret · Marine Agisson · Euengla Uku · Thibault Saurel · Vincent JanninFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1770094
ReviewPublished 4 May 2026Oral delivery of biologics: from barrier-limited formulation to active convective transportSarfaraz K. NiaziFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1783113
Mini ReviewPublished 24 March 2026Navigating the complexity of oral peptide delivery: challenges and strategies to enhance oral bioavailabilityNoor-Ul-Ain Khalid · Edgardo Rivera-Delgado · Thomas von ErlachFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1809842
ReviewPublished 20 March 2026Oral delivery of peptides and proteins: pharmacokinetic boundaries, negative selection, and route triageSarfaraz K. NiaziFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1776167
Original ResearchPublished 27 January 2026The “yeast-drop” treatment protocol in the Drosophila model for rapid and cost-effective TB drug testingMaria Vidal · Esther Fuentes · Nerea Escobar · Marta Arch · Pere-Joan CardonaFrontiers in Tuberculosisdoi 10.3389/ftubr.2026.1746664
Drug DeliveryPublished 6 November 2024Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral deliveryR. R. C. New · M. Bogus · G. N. Travers · U. Hahn · A. Vaiceliunaite · M. Burnet · J. H. Wang · H. WenFrontiers in Drug Deliverydoi 10.3389/fddev.2024.1456654